The Complexity Of The MAPK Pathway

Our article this week talks about how the MAPK pathway is highly linked with several neurological diseases including Alzheimer’s Disease, Parkinson’s Disease, ALS – Almytotropic lateral sclerosis (or Lou Gehrig’s Disease), and cancer. A single pathway that is connected with so many influential diseases is exciting in that it offers a great deal of potential…
Read More

Rethinking Reasons For Weight Loss: Alzheimer’s And Type II Diabetes

I don’t mean to harp on body image and societal pressures too much. I know that this was my topic last week, but our article this week begs me to write a second post about the topic. I am one of the two thirds of Americans who are overweight or obese and like so many…
Read More

Diseases Inhibited By Pharmaceutical Inhibitors

We live in a society where drugs (pharmaceuticals) dominate the medical world. Are you clinically depressed? Try Lexapro or Cymbalta. Is your cholesterol too high? Maybe Lipitor or Zocor will work for you. But don’t forget that drugs rarely work in the body without unwanted side effects! Why is this? How do pharmaceuticals work? The…
Read More

Isolating Cell Signalling

Our topic this week was the MAPK pathways. Quite simply, the MAPK pathways are a series of signalling molecules that carry messages from outside sources into the cell’s nucleus. This signal is carried from a receptor on the surface of the cell activating a signalling molecule. After that signalling molecule is activated, a signal cascade…
Read More

Quality Of Life And End Of Life Decisions

In a discussion of neurodegenerative diseases, especially those that appear as late-onset varieties, a question arises about prolonging life and improving quality of life.   Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig’s disease, is a neurodegenerative disease involving the loss of motor neurons to the point of muscle atrophy.  This results in weakness and an eventual…
Read More